These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23405581)

  • 1. [Psychotropic substances and driving].
    Bordini L; Riboldi L; Ferrario MM
    G Ital Med Lav Ergon; 2012; 34(3 Suppl):54-7. PubMed ID: 23405581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drivers involved in road traffic accidents in Piedmont Region: psychoactive substances consumption.
    Siliquini R; Chiadò Piat S; Gianino MM; Renga G
    J Prev Med Hyg; 2007 Dec; 48(4):123-8. PubMed ID: 18557306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Psychoactive drugs and accident risk in road traffic].
    Lillsunde P; Langel K; Blencowe T; Kivioja A; Karjalainen K; Lehtonen L
    Duodecim; 2012; 128(18):1877-86. PubMed ID: 23088001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C; Polard E; Mauduit N; Allain H
    Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Psychoactive drugs and fitness to drive in the occupational field].
    Paraluppi P; Fassina G; Ferrari G; Tronconi L
    G Ital Med Lav Ergon; 2009; 31(1):33-6. PubMed ID: 19558037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The "Driving under the Influence of Drugs, Alcohol and Medicines" (DRUID) project of the European Commission].
    Albrecht M
    Dtsch Med Wochenschr; 2008 Jun; 133 Suppl 2():S45-6. PubMed ID: 18548371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mad drivers: psychiatric illness and driving performance.
    Cremona A
    Br J Hosp Med; 1986 Mar; 35(3):193-5. PubMed ID: 3742131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Professional drivers and psychoactive substances consumption: results from medical surveillance at the workplace in Piedmont region].
    Rosso GL; Feola M; Rubinetto MP; Petti N; Rubinetto L
    G Ital Med Lav Ergon; 2011; 33(3 Suppl):203-6. PubMed ID: 23393836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alcohol, drugs and traffic laws. 2: Studies of the assessment of significant disability in automobile driving fitness caused by psychotropic drugs or alcohol and psychotropic drug combinations].
    Eulitz J; Krause D; Herold C; Brier C; Koch R
    Z Arztl Fortbild (Jena); 1986; 80(19):823-6. PubMed ID: 3811420
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of psychoactive drugs on car driving ability].
    Brunnauer A; Laux G
    Dtsch Med Wochenschr; 2008 Jun; 133 Suppl 2():S38-40. PubMed ID: 18548369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Random and systematic errors in case-control studies calculating the injury risk of driving under the influence of psychoactive substances.
    Houwing S; Hagenzieker M; Mathijssen RP; Legrand SA; Verstraete AG; Hels T; Bernhoft IM; Simonsen KW; Lillsunde P; Favretto D; Ferrara SD; Caplinskiene M; Movig KL; Brookhuis KA
    Accid Anal Prev; 2013 Mar; 52():144-53. PubMed ID: 23333321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Workplace and psychoactive substances dependence: certificate of eligibility for work and perspectives of prevention in the light of recent innovative regulations].
    Spigno F; Debarbieri N; Traversa F
    G Ital Med Lav Ergon; 2007; 29(2):158-65. PubMed ID: 17886756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychoactive medication and traffic safety.
    Verster JC; Mets MA
    Int J Environ Res Public Health; 2009 Mar; 6(3):1041-54. PubMed ID: 19440432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medication, narcotics and behavior at the wheel].
    Mercier-Guyon C
    Bull Acad Natl Med; 1994 Jun; 178(6):1111-20; discussion 1120-2. PubMed ID: 7994584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of chronic pain patients' psychotropic drug knowledge and warning labels on the decision whether to drive a car or not.
    Veldhuijzen DS; van Wijck AJ; Verster JC; Kalkman CJ; Kenemans JL; Olivier B; Volkerts ER
    Traffic Inj Prev; 2006 Dec; 7(4):360-4. PubMed ID: 17114093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Consumption of psychoactive substances by caregivers].
    Gauthier F
    Rev Infirm; 2012 Nov; (185):25-6. PubMed ID: 23173489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Measures against driving under the influence of drugs--the county medical officer's role. A 2-year material from Vest-Agder].
    Steen TW; Hagestad K; Hagerup-Jenssen T; Wroldsen A
    Tidsskr Nor Laegeforen; 1997 Sep; 117(21):3093-6. PubMed ID: 9381444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are actual driving tests necessary for evaluating drug safety?
    O'Hanlon JF
    Int Clin Psychopharmacol; 1988 May; 3 Suppl 1():81-5. PubMed ID: 3403953
    [No Abstract]   [Full Text] [Related]  

  • 19. The relationship between performance on the standardised field sobriety tests, driving performance and the level of Delta9-tetrahydrocannabinol (THC) in blood.
    Papafotiou K; Carter JD; Stough C
    Forensic Sci Int; 2005 Dec; 155(2-3):172-8. PubMed ID: 16226154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Driving fitness/driving capacity of patients treated with methadone].
    Hauri-Bionda R; Bär W; Friedrich-Koch A
    Schweiz Med Wochenschr; 1998 Oct; 128(41):1538-47. PubMed ID: 9816613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.